IDH1 and central nervous system cancer: Even if this work was mostly performed in leukemia cells, and all mechanistic demonstrations were made in that context, the authors also showed that R-2HG can inhibit the proliferation of a panel of glioma cell lines, all IDH1/2 wild type.